News
Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release
See all News
Daniel S. Levine
Managing Director
Prior to joining Burrill & Company in April 2007, Mr. Levine worked as special projects editor for the San Francisco Business Times where he won numerous awards for his coverage of the biotechnology industry. His work has appeared in the New York Times, The Industry Standard and theStreet.com as well as other national publications. He is the author of Disgruntled: The Darker Side of the World of Work, (Berkley/Boulevard Books). Before he became a journalist, Mr. Levine served as a Vice President and General Principal with Herbert Young Securities in Great Neck, NY. He holds an AB in English from Vassar College and a Masters in Journalism from the University of California, Berkeley.